Cargando…

Discovery of Novel HPK1 Inhibitors Through Structure-Based Virtual Screening

Hematopoietic progenitor kinase (HPK1) is a negative regulator of T-cell receptor and B-cell signaling, which has been recognized as a novel antitumor target for immunotherapy. In this work, Glide docking-based virtual screening and kinase inhibition assay were performed to identify novel HPK1 inhib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Huizhen, Peng, Lizeng, Sun, Zhou, Liu, Huanxiang, Shen, Yulin, Yao, Xiaojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967249/ https://www.ncbi.nlm.nih.gov/pubmed/35370676 http://dx.doi.org/10.3389/fphar.2022.850855

Ejemplares similares

Discovery of Novel IDH1 Inhibitor Through Comparative Structure-Based Virtual Screening
por: Wang, Yuwei, et al.
Publicado: (2020)

Theoretical Studies on Selectivity of HPK1/JAK1 Inhibitors by Molecular Dynamics Simulations and Free Energy Calculations
por: Ge, Huizhen, et al.
Publicado: (2023)

Discovery of Novel Inhibitors of Indoleamine 2,3-Dioxygenase 1 Through Structure-Based Virtual Screening
por: Zhang, Guoqing, et al.
Publicado: (2018)

Discovery of novel IDH1-R132C inhibitors through structure-based virtual screening
por: Hu, Chujiao, et al.
Publicado: (2022)

Discovery of METTL3 Small Molecule Inhibitors by Virtual Screening of Natural Products
por: Du, Yue, et al.
Publicado: (2022)

Discovery of potent and noncovalent KRAS(G12D) inhibitors: Structure-based virtual screening and biological evaluation
por: Wang, Yuting, et al.
Publicado: (2022)

Identification of a Novel Protein Arginine Methyltransferase 5 Inhibitor in Non-small Cell Lung Cancer by Structure-Based Virtual Screening
por: Wang, Qianqian, et al.
Publicado: (2018)

Discovery of novel anti-tumor compounds targeting PARP-1 with induction of autophagy through in silico and in vitro screening
por: Shi, Danfeng, et al.
Publicado: (2022)

Integrating Machine Learning-Based Virtual Screening With Multiple Protein Structures and Bio-Assay Evaluation for Discovery of Novel GSK3β Inhibitors
por: Zhu, Jingyu, et al.
Publicado: (2020)

Discovery of Novel and Highly Potent Inhibitors of SARS CoV-2 Papain-Like Protease Through Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, Molecular Dynamics Simulations, and Biological Evaluation
por: Tian, Xiaoyan, et al.
Publicado: (2022)

Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor
por: You, Dan, et al.
Publicado: (2021)

Discovery of a Series of Theophylline Derivatives Containing 1,2,3-Triazole for Treatment of Non-Small Cell Lung Cancer
por: Ye, Jiahui, et al.
Publicado: (2021)

QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery
por: Neves, Bruno J., et al.
Publicado: (2018)

Discovery of Potent Disheveled/Dvl Inhibitors Using Virtual Screening Optimized With NMR-Based Docking Performance Index
por: Hori, Kiminori, et al.
Publicado: (2018)

HPK1 tones down the T cell receptor
por: Leslie, Mitch
Publicado: (2011)

Drug Discovery of DKK1 Inhibitors
por: Jiang, Hewen, et al.
Publicado: (2022)

Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis
por: Liu, Jiawei, et al.
Publicado: (2022)

Synthesis and Antitumor Activity of Erlotinib Derivatives Linked With 1,2,3-Triazole
por: Deng, Peng, et al.
Publicado: (2022)

Discovery of Chitin Deacetylase Inhibitors through Structure-Based Virtual Screening and Biological Assays
por: Liu, Yaodong, et al.
Publicado: (2022)

Identification of PARP12 Inhibitors By Virtual Screening and Molecular Dynamics Simulations
por: Almeleebia, Tahani M., et al.
Publicado: (2022)

Virtual screening and activity evaluation of multitargeting inhibitors for idiopathic pulmonary fibrosis
por: Wang, Rui, et al.
Publicado: (2022)

A perspective on HPK1 as a novel immuno-oncology drug target
por: Sawasdikosol, Sansana, et al.
Publicado: (2020)

Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening
por: Kumar, Rajnish, et al.
Publicado: (2017)

Characterisation of 50 μm thick LGAD manufactured by FBK & HPK
por: Sola, V., et al.
Publicado: (2019)

Evaluation of novel KEK/HPK n-in-p pixel sensors for ATLAS upgrade with testbeam
por: Nagai, R, et al.
Publicado: (2013)

Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening
por: Divsalar, Donya Naz, et al.
Publicado: (2020)

Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening
por: Atatreh, Noor, et al.
Publicado: (2019)

Discovery of TMPRSS2 inhibitors from virtual screening
por: Hu, Xin, et al.
Publicado: (2021)

Layout and Performance of HPK Prototype LGAD Sensors for the High-Granularity Timing Detector
por: Yang, X., et al.
Publicado: (2020)

Discovery of New α-Glucosidase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation
por: Liu, Shan-Kui, et al.
Publicado: (2021)

Identification of a novel P2X7 antagonist using structure-based virtual screening
por: Pasqualetto, Gaia, et al.
Publicado: (2023)

Discovery of Akt Kinase Inhibitors through Structure-Based Virtual Screening and Their Evaluation as Potential Anticancer Agents
por: Chuang, Chih-Hung, et al.
Publicado: (2015)

Novel Virtual Screening Approach for the Discovery of Human Tyrosinase Inhibitors
por: Ai, Ni, et al.
Publicado: (2014)

Discovery of pyrrole derivatives as acetylcholinesterase-sparing butyrylcholinesterase inhibitor
por: Sun, Shouyuan, et al.
Publicado: (2022)

Identification of novel and potent dual-targeting HDAC1/SPOP inhibitors using structure-based virtual screening, molecular dynamics simulation and evaluation of in vitro and in vivo antitumor activity
por: Yang, Yingxue, et al.
Publicado: (2023)

Radiation campaign of HPK prototype LGAD sensors for the High-Granularity Timing Detector (HGTD)
por: Shi, X., et al.
Publicado: (2020)

Empirical Scoring Functions for Structure-Based Virtual Screening: Applications, Critical Aspects, and Challenges
por: Guedes, Isabella A., et al.
Publicado: (2018)

Computational Insights Into the Inhibition Mechanism of Proanthocyanidin B2 on Tau Hexapeptide (PHF6) Oligomer
por: Li, Qin, et al.
Publicado: (2021)

Discovery of novel benzylquinazoline molecules as p97/VCP inhibitors
por: Zhang, Xiaoyi, et al.
Publicado: (2023)

Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening
por: Vidler, Lewis R., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_q5j99k20ct1a8qkiq0b0s2sbna